Clinical trial
The Effect of Dexmedetomidine of the Immune System
NCT01692210
Study timeline
Study start (unknown)2012-09-01Date precision: month
Registry last updated2016-01-07
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Breast Cancerunresolved
Interventions
DexmedetomidineDRUG · verified · RxNorm: dexmedetomidine
Sponsors & collaborators
M.D. Anderson Cancer Centerlead sponsor
Hospira, now a wholly owned subsidiary of Pfizercollaborator
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT01692210 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.